| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.43 | 0.02 |